ReviewAnimal models and experimental medicine2025
Multimorbidity and animal models.
Review in Animal models and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimorbidity and animal models.Animal models and experimental medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Multimorbidity-the co-occurrence of more than two chronic conditions in the same individual-is associated with premature death, diminished function, reduced quality of life, and increased societal burden. This complex state involves dynamic interactions across multiple conditions, organ systems, and physiological pathways; yet research progress remains constrained by inadequate animal models that recapitulate human complexity. This review summarizes the predominant patterns of multimorbidity and evaluates current animal models spanning invertebrates, rodents, and large mammals. While no single model fully captures the multifaceted nature of human multimorbidity, we propose several strategic directions to address existing limitations: implementing a cross-species validation framework (from simple organisms to rodents to large mammals), standardizing protocols integrating multimodal risk factors, developing advanced non-animal models, and enhancing ethical oversight. Advancing multimorbidity models is crucial for decoding disease interactions and accelerating translation of research findings into improved patients outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.